Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Annabel Z Wang"'
Autor:
Qiulun Lu, Yufeng Yao, Zhenkun Hu, Changqing Hu, Qixue Song, Jian Ye, Chengqi Xu, Annabel Z Wang, Qiuyun Chen, Qing Kenneth Wang
Publikováno v:
PLoS Biology, Vol 14, Iss 8, p e1002529 (2016)
AGGF1 is an angiogenic factor with therapeutic potential to treat coronary artery disease (CAD) and myocardial infarction (MI). However, the underlying mechanism for AGGF1-mediated therapeutic angiogenesis is unknown. Here, we show for the first time
Externí odkaz:
https://doaj.org/article/cb1cb9e8602444b68f986e237e79e22a
Publikováno v:
MDM Policy & Practice, Vol 2 (2017)
Background: Many health policy experts have endorsed insurance competition as a way to reduce the cost and improve the quality of medical care. In line with this approach, health insurance exchanges, such as HealthCare.gov , allow consumers to compar
Externí odkaz:
https://doaj.org/article/8cd4ee989261460ba8a88a67bff2c810
Publikováno v:
JAMA network open. 5(7)
Although screenings for breast and colorectal cancer are widely recommended, patient screening rates vary greatly and remain below public health targets, and primary care physicians' (PCPs') counseling and referrals play critical roles in patients' u
Autor:
Jisheng Sun, Elizabeth A. Peterson, Annabel Z. Wang, Jianhong Ou, Kieko E. Smith, Kenneth D. Poss, Jinhu Wang
Publikováno v:
Circulation
Background:Certain nonmammalian species such as zebrafish have an elevated capacity for innate heart regeneration. Understanding how heart regeneration occurs in these contexts can help illuminate cellular and molecular events that can be targets for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35bed9a89b772b1da4d30061bf6eb365
https://europepmc.org/articles/PMC9308751/
https://europepmc.org/articles/PMC9308751/
Autor:
Annabel Z. Wang, J. Michael McWilliams
Publikováno v:
JAMA Health Forum. 4:e230040
This cross-sectional study compares care experiences and outpatient visit use between physician-patients and nonphysician-patients.
Publikováno v:
MDM Policy & Practice
Background: Many health policy experts have endorsed insurance competition as a way to reduce the cost and improve the quality of medical care. In line with this approach, health insurance exchanges, such as HealthCare.gov, allow consumers to compare
Publikováno v:
Annals of Human Genetics. 75:475-482
Recent genome-wide single nucleotide polymorphism (SNP) association studies (GWAS) have identified a number of SNPs that were significantly associated with coronary artery disease and myocardial infarction (MI). However, many independent replication
Publikováno v:
Journal of Clinical Oncology. 35:10054-10054
10054 Background: Many patients with acute myeloid leukemia (AML) face a difficult choice about whether to receive palliative chemotherapy or high-dose, potentially-curative chemotherapy that poses a risk of early death. How people weigh these factor
Publikováno v:
Journal of Clinical Oncology. 34:35-35
35 Background: Many patients with acute myeloid leukemia (AML) face a difficult choice about whether to receive palliative chemotherapy or high-dose, potentially-curative chemotherapy that poses a risk of early death. How people weigh these factors i
Autor:
Qing Kenneth Wang, Qixue Song, Jian Ye, Qiuyun Chen, Yufeng Yao, Changqing Hu, Chengqi Xu, Annabel Z. Wang, Zhenkun Hu, Qiulun Lu
Publikováno v:
PLoS Biology
PLoS Biology, Vol 14, Iss 8, p e1002529 (2016)
PLoS Biology, Vol 14, Iss 8, p e1002529 (2016)
AGGF1 is an angiogenic factor with therapeutic potential to treat coronary artery disease (CAD) and myocardial infarction (MI). However, the underlying mechanism for AGGF1-mediated therapeutic angiogenesis is unknown. Here, we show for the first time